Table 2.
Study Population Use of Diabetes Medicationsa
| Diabetes Medication Type | Diabetic Patients, No. (%) |
P Value Based on t Test |
All Diabetic Patients, No. (%) |
|
|---|---|---|---|---|
| Did Not Develop OAG | Developed OAG | |||
| Sulfonylureas | 44 659 (31.0) | 1846 (31.3) | .58 | 46 505 (31.0) |
| Metformin hydrochloride | 57 993 (40.2) | 2221 (37.7) | <.001 | 60 214 (40.1) |
| Thiazolidinediones | 34 265 (23.8) | 1442 (24.5) | .22 | 35 707 (23.8) |
| Meglitinides | 3510 (2.4) | 153 (2.6) | .43 | 3663 (2.4) |
| Insulin | 32 704 (22.7) | 1244 (21.1) | .005 | 33 948 (22.6) |
| Othersb | 10 536 (7.3) | 283 (4.8) | <.001 | 10 819 (7.2) |
Abbreviation: OAG, open-angle glaucoma.
a
Some enrollees were prescribed more than 1 medication class.
b
Exenatide, sitagliptin, or pramlintide.